期刊文献+

HPLC测定人血浆中伏立康唑的血药浓度 被引量:1

Detemination of Plasma Voriconazole Concentrations by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱(HPLC)快速测定人血浆中伏立康唑血药浓度的方法。方法血浆样品经甲醇沉淀后,以甲醇-水=63∶37为流动相,流速为1.0m L·min^-1,色谱柱为Agilent 5HC-C 18(250×4.6mm,5μm),柱温为30℃,紫外检测波长为260nm。结果该法专属性较好,血浆中杂质不干扰样品峰的测定;伏立康唑在0.25~25mg·L^-1质量浓度范围内线性关系良好,所获回归方程为Y=26.115X-2.0302(R 2=0.9997);批内、批间精密度和准确度均小于15%;血浆样品室温及4℃放置24h,样品稳定性均较好。结论HPLC灵敏、快速、准确,操作简便、线性范围宽,可用于伏立康唑的临床血药浓度监测。 OBJECTIVE To establish a method for determining the concentration of voriconazole in human plasma by HPLC.METHODS Plasma samples were precipitated with methanol and separation was carried out on a Agilent 5HC-C 18(250×4.6mm,5μm)at 30℃.The mobile phase consisted of methanol-water(63∶37)at a flow rate of 1.0mL·min^-1.The detecting wave le ngth was 260nm.RESULTS The intrinsic impurity of plasma did not interfere with the determination of the analyte.The linearity was good in the concentration range from 0.25 to 25.0mg·L^-1 and the linear relationship was Y=26.115X-2.0302(R 2=0.9997).The precision and accuracy within batches and between batches were both less than 15%.Plasma samples had a good stability after placement at room temperature and 4℃for 24 hours.CONCLUSION The established HPLC method is fast,sensitive,and accurate,which can be applied to the serum concentration monitoring of voriconazole.
作者 高元峰 欧阳林旗 肖望重 欧阳荣 GAO Yuan-feng;OUYANG Lin-qi;XIAO Wang-zhong;OUYANG Rong(The First Hospital of Hunan University of Chinese Medicine,Changsha 410007,China)
出处 《海峡药学》 2020年第5期29-32,共4页 Strait Pharmaceutical Journal
基金 湖南省中医药管理局临床药学重点专科(湘中医药函〔2017〕11号)。
关键词 伏立康唑 高效液相色谱法 外标法 血药浓度 Voriconazole HPLC:External standard method Serum concentration
  • 相关文献

参考文献7

二级参考文献69

  • 1St'ephanie Chhun, Elisabeth Rey, Agnes Tran, et al. Simultaneous quantification of vorieonazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection [J] Journal of Chromatography B, 6, (2007),1 5.
  • 2G Srinubabu, Ch AI Raju N Sarathb, et al. Development and validation of a HPLC method for the determination of voricon azole in pharmaceutical formulation using an experimental design[J]. Talanta, 71, (2007): 1424- 1429.
  • 3高洪志,梁宇光,林丽娜,胡锦超,刘泽源.2种伏立康唑片剂的人体生物等效性研究[J].中国新药杂志,2007,16(14):1133-1136. 被引量:7
  • 4黄成坷,邱相君,胡国新,代宗顺.伏立康唑分散片人体生物等效性研究[J].中国药学杂志,2007,42(16):1241-1243. 被引量:13
  • 5史卉妍,彭亮,谭志荣,康桢,何鑫,罗丽芳,吴卫华,阳国平,欧阳冬生.高效液相色谱法测定人血浆中伏立康唑浓度[J].中南药学,2007,5(4):305-308. 被引量:29
  • 6Keady S,Thacker M.Voriconazole in the treatment of in-vasive fungal infections[J].Intensive Crit Care Nurs,2005,21(6):370.
  • 7Ben-Ami R,Lewis RE,Kontoyiannis DP.Immunocompro-mised hosts:immunopharmacology of modern antifungals[J].Clin Infect Dis,2008,47(2):226.
  • 8Purkins L,Wood N,Ghahramani P,et al.Pharmacokinet-ics and safety of voriconazole following intravenous-to oral-dose escalation regimens[J].Antimicrob Agents Che-mother,2002,46(8):2546.
  • 9Purkins L,Wood N,Kleinermans D,et al.Effect of food on the pharmacokinetics of multiple-dose oral voricon-azole[J].Br J Clin Pharmacol,2003,56(Suppl1):17.
  • 10Lazarus HM,Blumer JL,Yanovich S,et al.Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection:a dose escalation study[J].J Clin Pharmacol,2002,42(4):395.

共引文献117

同被引文献18

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部